Compare DERM & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | SATL |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.4M | 482.3M |
| IPO Year | 2021 | N/A |
| Metric | DERM | SATL |
|---|---|---|
| Price | $4.78 | $6.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $12.67 | $5.50 |
| AVG Volume (30 Days) | 141.1K | ★ 6.9M |
| Earning Date | 03-25-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $66.12 | $68.54 |
| Revenue Next Year | $52.94 | $56.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $5.64 | $1.26 |
| 52 Week High | $9.56 | $6.84 |
| Indicator | DERM | SATL |
|---|---|---|
| Relative Strength Index (RSI) | 19.84 | 82.81 |
| Support Level | N/A | $3.18 |
| Resistance Level | $8.05 | N/A |
| Average True Range (ATR) | 0.54 | 0.55 |
| MACD | -0.21 | 0.39 |
| Stochastic Oscillator | 0.00 | 90.16 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.